Main Subject - Business

Some financial planners think that they shouldn't share their top tip

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

s with the media.

I can see some validity in thinking this way. Afte

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

all, the media is going to deliver these tips to the public at pract

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ically no charge. Then all those people who might have been paying cu

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

tomers won't have any use for their services.

But there's two things

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

wrong with this:

First of all, it's true that most people are likely

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

to use your information and never contact you. Then again, most peop

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e aren't likely to use a financial planner. The people you want to re

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ach are that fraction that are looking, perhaps even subconsciously,

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

or help with their investments. When they see your name in the paper,

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

regardless of the information it is connected to, they will think abo

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ut calling you.

Second, you aren't the only financial planner lookin

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

for publicity. And unless your wisdom far exceeds that of any other

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

financial planner in the world, you'd better believe that your compet

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

tors will be offering practically the same information to the media.

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

n the end, not only is the information disseminated after all, but yo

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

u lose the chance to take credit for it.

Part of being a good media

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

esource is delivering lots of good information. So share everything y

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ou’ve got. Hold back nothing. With journalists, “saving the good stuf

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

” for paying customers is a certain ticket to becoming a media fiasco

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/34020/mainsubjects-MarketingMinded-Financial-Planners-Dont-Hold-Back-Information-From-the-Media.html">Marketing-Minded Financial Planners, Don't Hold Back Information From the Media</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/34020/mainsubjects-MarketingMinded-Financial-Planners-Dont-Hold-Back-Information-From-the-Media.html]Marketing-Minded Financial Planners, Don't Hold Back Information From the Media[/url]

This article provides an introduction to financial accounting, its purpose, the four basic financial statements, and the concept of generally accepted accounting principles (GAAP) which is used to prepare these financial statements.

The ability to delegate effectively is a crucial management skill that results in employee engagement and retention. There are six factors that must be in place for employees to feel engaged.

The manager's path to quality public relations requires that you resolve to do something about the behaviors of those outside audiences that most affect the unit you manage. And that's for starters.

Tags

Links

Main Subject - Marketing-Minded Financial Planners, Don't Hold Back Information From the Media

Related Articles: